SI-BONE/ US8257041090 /
6/5/2024 9:14:05 PM | Chg. +0.27 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
14.02USD | +1.96% | 3,624 Turnover: 50,163.81 |
-Bid Size: - | -Ask Size: - | 14.03 | 13.52 |
GlobeNewswire
5/7
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant Syst...
GlobeNewswire
3/4
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
GlobeNewswire
2/26
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Gui...
GlobeNewswire
2/5
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
GlobeNewswire
1/30
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant wit...
GlobeNewswire
11/14/2023
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
GlobeNewswire
11/6/2023
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidanc...
GlobeNewswire
11/1/2023
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
GlobeNewswire
9/5/2023
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic C...
GlobeNewswire
8/29/2023
SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
GlobeNewswire
2/28/2022
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Gu...
GlobeNewswire
2/1/2022
SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
GlobeNewswire
12/13/2021
SI-BONE, Inc. Announces Updated Exclusive Blue Cross Blue Shield Association Evidence Street Opinion...
GlobeNewswire
11/8/2021
SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance